Verified

Chronic Pain Medicine Research Grant

American Society of Regional Anesthesia and Pain Medicine

ASRA Pain Medicine is recognized as a leading organization in the advancement of the science and practice of pain medicine. The ASRA Pain Medicine Chronic Pain Medicine Research Grant aims to promote and facilitate high quality research in pain medicine. Results of such research will guide clinical practice for pain physicians and improve patient health care. This research is needed to evaluate the efficacy and safety of pain interventions and treatments.

Financial Support

ASRA Pain Medicine invites and greatly appreciates your financial generosity in supporting the Chronic Pain Medicine Research fund. Both individual and corporate donations are welcome. ASRA Pain Medicine is committed to be the largest contributor to this research fund, and to facilitate a rapid growth of funds towards high caliber pain research. Your support to this fund will be recognized by the ASRA Pain Medicine Board of Directors at the annual meetings. [return to top]

ASRA Pain Medicine’s Chronic Pain Research Grant Priorities

ASRA Pain Medicine will support research related to Regional Anesthesia, Acute and Chronic Pain in the following areas:

Basic and Laboratory Sciences
Population Sciences
Outcomes Research
Clinical Sciences
Methodology Research
Drug/Protocol Development
Patient Safety
Education
Policy Research
Health Services Research

Letter of Intent Process and Guidelines

Please refer to the Chronic Pain Research Grant Priorities, determined by ASRA Pain Medicine leadership for this cycle, which are recommended but not required. This does not mean that you cannot apply for an area of research outside the scope of the priorities listed.

Letters of intent (LOIs) are limited to 1 page, not including biosketch. This high-level, succinct overview will encompass critical objectives, resources requested, and outcomes to be achieved. The ASRA Pain Medicine Research Committee will review all LOIs to ensure they meet grant objectives. Submitters of accepted projects will then be asked to submit a full grant proposal.

Narrative Requirements:

Objectives of the proposed clinical trial and hypothesis to be tested
- Background
- Hypothesis
- Objectives
ASRA Pain Medicine priority addressed in this application
Research environment
Research team (include biosketch max 100 words per applicant)

Timeline and Process

July 1, 2026 - October 1, 2026 – LOIs will be accepted during those dates. Complete the Narrative Requirements, and provide typed in 10 pt Times New Roman, no longer than 1 page, not including biosketch, and submitted as a single file only PDF format.
October 1, 2026 – LOIs are due by 11:59 pm ET to asrassistant@asra.com. Late or incomplete submissions will not be considered.
By mid-November 2026 – The ASRA Pain Medicine Research Committee will notify those selected to submit grant proposals. The Committee will also respond to those not selected to submit a full grant proposal.
February 1, 2027 – Invited grant proposals are due by 11:59 pm ET.
At the Spring Board of Directors meeting – Board of Directors will determine final awardee based upon recommendations from ASRA Pain Medicine Research Committee.
May 15, 2027- ASRA Pain Medicine Research Committee will notify grant awardee(s).

AI Based Application Success Predictor

1. Direct ASRA relevance ⭐⭐⭐⭐⭐

This is the most important factor.

High-fit research includes:

Regional anesthesia
Peripheral nerve blocks
Neuraxial anesthesia
Acute postoperative pain
Chronic pain
Interventional pain procedures
Perioperative pain management
Ultrasound-guided regional anesthesia
Pain-related patient outcomes
Opioid-sparing strategies
Neuropathic pain
Cancer pain
Musculoskeletal pain
Pain education and delivery

A general anesthesiology project with no meaningful regional-anesthesia or pain component would have weaker fit.

2. Important unmet clinical need ⭐⭐⭐⭐⭐

The proposal should identify a meaningful problem in pain or anesthesia care.

Examples:

Inadequate postoperative analgesia
Opioid-related adverse effects
Persistent postsurgical pain
Failed or incomplete nerve blocks
Block-related complications
Difficult pain control
Chronic neuropathic pain
Ineffective pain interventions
Health disparities in pain treatment
Lack of evidence for a particular regional technique

The strongest proposals clearly connect:

Clinical problem → knowledge gap → intervention/research question → patient benefit.

3. Patient outcomes and pain control ⭐⭐⭐⭐⭐

ASRA-aligned research should ultimately improve outcomes such as:

Pain intensity
Functional recovery
Patient satisfaction
Opioid consumption
Recovery time
Hospital length of stay
Postoperative nausea/vomiting
Mobility
Chronic pain development
Quality of life
Procedure-related safety

A proposal becomes much stronger when the primary scientific endpoint has a clear clinical meaning.

4. Scientific merit ⭐⭐⭐⭐⭐

The study should have a clearly defined question or hypothesis.

A strong proposal should explain:

What is already known?
What remains uncertain?
Why is the uncertainty clinically important?
What hypothesis will be tested?
What new knowledge will the project produce?

For example:

Uncertain optimal nerve-block strategy → randomized comparison → pain/opioid outcomes → evidence for clinical practice

5. Methodological rigor ⭐⭐⭐⭐⭐

Particularly important for ASRA clinical research are:

Appropriate study design
Randomization where appropriate
Appropriate comparator
Adequate sample size
Blinding where feasible
Standardized anesthesia/analgesia protocols
Clearly defined pain endpoints
Opioid-consumption measurements
Appropriate statistical analysis
Safety monitoring

For procedural studies, the technique should be described sufficiently to permit reproducibility.

6. Innovation ⭐⭐⭐⭐⭐

Potentially competitive areas include:

Regional anesthesia

Novel nerve blocks
New block techniques
Improved block duration
Ultrasound-guided approaches
Continuous peripheral nerve catheters

Pain medicine

Novel interventions
Neuromodulation
Non-opioid therapies
Multimodal analgesia
Personalized pain management

Technology

AI-assisted ultrasound
Automated nerve identification
Digital pain assessment
Wearable pain monitoring
Imaging-guided interventions

Pharmacology

Novel local-anesthetic approaches
Adjuvants
Opioid-sparing regimens
Long-acting analgesic strategies

Innovation is strongest when it addresses a specific clinical limitation.

7. Clinical/translational potential ⭐⭐⭐⭐⭐

ASRA-relevant research should ideally move toward actual clinical practice.

A strong pathway is:

Research finding → clinical validation → practice change → improved pain/anesthesia outcome

Examples:

New nerve-block technique → lower opioid use → faster recovery

Pain biomarker → patient-risk stratification → individualized analgesia

Novel analgesic strategy → reduced opioid exposure → improved recovery

8. Feasibility ⭐⭐⭐⭐⭐

The proposal should demonstrate access to:

Appropriate surgical patients
Regional anesthesia expertise
Ultrasound equipment
Pain clinics
Anesthesia research infrastructure
Clinical research coordinators
Statistical support
Appropriate follow-up systems

A focused study that can be completed within the grant period is preferable to an overly ambitious project.

9. Investigator qualifications and mentorship ⭐⭐⭐⭐☆

Reviewers are likely to value evidence that the research team can successfully execute the study.

Relevant qualifications include:

Anesthesiology
Regional anesthesia
Pain medicine
Perioperative medicine
Clinical research
Biostatistics
Relevant laboratory expertise

For trainees and early-career researchers, a strong senior mentor can strengthen the application considerably.

10. Future research potential ⭐⭐⭐⭐☆

A smaller ASRA project becomes more compelling if it establishes the foundation for:

Pilot data → larger study → multicenter trial → practice-changing evidence

The proposal should therefore explain what the investigators intend to do after the initial study.

Specialties

Pain Medicine

Eligibility Requirements

The applicant and co-investigators must be North American, physician members of ASRA Pain Medicine.
The amount of the award will not exceed $75,000.
All requests for funds will be considered, and the committee retains the right to divide the available funds in any manner it deems appropriate with agreement of the investigators involved.
The research proposal must be concerned with an original idea or concept (i.e., has not been done before). The research must be carried out primarily by the applicant. Assistance by or collaboration with other academic faculty or staff anesthesiologists is permitted; these secondary investigators must be identified in the application.
The grant requests can be for clinical research projects or research using laboratory animals.

Eligible Countries:

Canada

Mexico

United States

Sponsor Details

Sponsor Institute/Organizations: American Society of Regional Anesthesia and Pain Medicine

Sponsor Type: Corporate/Non-Profit

Address: 3 Penn Center West, Suite 121, Pittsburgh, PA 15276

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity